Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...

The anti-ID antibodies exhibit excellent titer specificity and little cross-reactivity with human IgG. Anti-idiotypic antibodies, both polyclonal and monoclonal, can be created to aid in drug ...

MOSCOW, June 29. /TASS/. A third dose of the Sputnik V vaccine is safe, and it may provide a higher antibody titer than the one observed after the first two doses, says Gamaleya Research Institute ...

The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.